Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

Bibliographic Details
Main Authors:	Aoki, Akiko, Ishiguro, Shin, Watanabe, Takashi, Ueda, Mikito, Hayashi, Yuki, Akiyama, Kazufumi, Kato, Kazuko, Inoue, Yoshimasa, Tsuchimine, Shoko, Yasui-Furukori, Norio, Shimoda, Kazutaka
Format:	Online
Language:	English
Published:	Dove Medical Press 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174019/

Similar Items

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder
by: Tomita, Tetsu, et al.
Published: (2014)

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
by: Saruwatari, Junji, et al.
Published: (2014)

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response
by: Tomita, Tetsu, et al.
Published: (2014)

Three year naturalistic outcome study of panic disorder patients treated with paroxetine
by: Dannon, Pinhas N, et al.
Published: (2004)

Efficacy of atropine combined with paroxetine in vagus nerve excitatory panic disorder
by: Du, Na, et al.
Published: (2015)

Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
by: Tsuchimine, Shoko, et al.
Published: (2013)

ABO Blood Type and Personality Traits in Healthy Japanese Subjects
by: Tsuchimine, Shoko, et al.
Published: (2015)

The Genetic Basis of Panic Disorder
by: Na, Hae-Ran, et al.
Published: (2011)

Tryptophan Research in Panic Disorder
by: Maron, Eduard, et al.
Published: (2008)

Panic Disorder and Agoraphobia
by: Barrow, Emma
Published: (2015)

Paroxetine in the treatment of recurrent brief depressive disorder
by: Prakash, Sathya, et al.
Published: (2013)

Panic disorders: The role of genetics and epigenetics
by: Eun Jeong Kim, et al.
Published: (2018-07-01)

Can pill placebo augment cognitive-behavior therapy for panic disorder?
by: Furukawa, Toshi A, et al.
Published: (2007)

No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan
by: Sugawara, Norio, et al.
Published: (2012)

Body composition in patients with schizophrenia: Comparison with healthy controls
by: Sugawara, Norio, et al.
Published: (2012)

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
by: Tsuruga, Koji, et al.
Published: (2014)

Cognitive-behavioral treatment of panic disorder with agoraphobia
by: Ponnusamy S.,, et al.
Published: (2005)

Panic disorder : symptomatology, medical utilisation and treatment.
by: Rees, Clare S.
Published: (1997)

Relationship between Personality and Insomnia in Panic Disorder Patients
by: Na, Hae-Ran, et al.
Published: (2011)

Venlafaxine extended release (XR) in the treatment of panic disorder
by: Kjernisted, Kevin, et al.
Published: (2007)

Hippocampal Neurochemical Pathology in Patients with Panic Disorder
by: Atmaca, Murad, et al.
Published: (2012)

Duloxetine in panic disorder with somatic gastric pain
by: Preve, Matteo, et al.
Published: (2013)

Orbito-Frontal Cortex Volumes in Panic Disorder
by: Atmaca, Murad, et al.
Published: (2012)

Fear of memories: the nature of panic in posttraumatic stress disorder
by: Joscelyne, Amy, et al.
Published: (2012)

The Effect of Agoraphobia on Oxidative Stress in Panic Disorder
by: Gul, Isil Gogcegoz, et al.
Published: (2013)

Temperament, character traits, and alexithymia in patients with panic disorder
by: Izci, Filiz, et al.
Published: (2014)

Cognitive-behavioral treatment of panic disorder with agoraphobia
by: Husna Zayadi
Published: (2005)

Xenon in the treatment of panic disorder: an open label study
by: Alexander Dobrovolsky, et al.
Published: (2017-06-01)

Increased mean platelet volume in patients with panic disorder
by: Kokacya, Mehmet Hanifi, et al.
Published: (2015)

Quality of Smartphone Apps Related to Panic Disorder
by: Van Singer, Mathias, et al.
Published: (2015)

Clinical Characteristics of the Respiratory Subtype in Panic Disorder Patients
by: Song, Hye-Min, et al.
Published: (2014)

Decreased mean platelet volume in panic disorder
by: Göğçegöz Gül, Işıl, et al.
Published: (2014)

Cortisol awakening response in drug-naïve panic disorder
by: Jakuszkowiak-Wojten, Katarzyna, et al.
Published: (2016)

Subregional Shape Alterations in the Amygdala in Patients with Panic Disorder
by: Yoon, Sujung, et al.
Published: (2016)

Enhanced anger superiority effect in generalized anxiety disorder and panic disorder
by: Ashwin, Chris, et al.
Published: (2012)

Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder
by: Koido, K, et al.
Published: (2012)

Differential attentional bias in generalized anxiety disorder and panic disorder
by: Chen, Jing, et al.
Published: (2013)

Sexual obsessions and suicidal behaviors in patients with mood disorders, panic disorder and schizophrenia
by: Dell’Osso, Liliana, et al.
Published: (2012)

The α-endomannosidase gene (MANEA) is associated with panic disorder and social anxiety disorder
by: Jensen, K P, et al.
Published: (2014)

Polymorphisms of IKBKE gene are associated with major depressive disorder and panic disorder
by: Traks, Tanel, et al.
Published: (2015)